EUVIMEDEUVIMED entdecken
Open Access

EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity

Yunfei Zhu, Xuetao Cao

Cancer Communications · 01.01.2026 · 46

DOI: 10.34133/cancomm.0027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, online erschienen am 14.05.2026. Verfasst von Yunfei Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, P. …. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, P. R. China.
  • Institute of Immunology, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Y., & Cao, X. (2026). EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0027

Vancouver

Zhu Y, Cao X. EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity. Cancer Communications. 2026;46. doi:10.34133/cancomm.0027

BibTeX
@article{Zhu2026,
  author = {Zhu, Yunfei and Cao, Xuetao},
  title = {EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8 + T Cell Immunity},
  journal = {Cancer Communications},
  year = {2026},
  volume = {46},
  doi = {10.34133/cancomm.0027}
}
Kostenlos starten →